-----BEGIN PRIVACY-ENHANCED MESSAGE-----
Proc-Type: 2001,MIC-CLEAR
Originator-Name: webmaster@www.sec.gov
Originator-Key-Asymmetric:
 MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen
 TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB
MIC-Info: RSA-MD5,RSA,
 P5kd3GCBnExoC73Iq8mp0EX3jQpNrnhSu9x6qQZRm3Okxeuhp4YXg55mjusaWFIo
 8s+/m7PvYI4bWqVbaJk8Sg==

<SEC-DOCUMENT>0001181431-08-005271.txt : 20080124
<SEC-HEADER>0001181431-08-005271.hdr.sgml : 20080124
<ACCEPTANCE-DATETIME>20080124185202
ACCESSION NUMBER:		0001181431-08-005271
CONFORMED SUBMISSION TYPE:	4
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20080122
FILED AS OF DATE:		20080124
DATE AS OF CHANGE:		20080124

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			MAP Pharmaceuticals, Inc.
		CENTRAL INDEX KEY:			0001401923
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				200507047
		STATE OF INCORPORATION:			DE

	BUSINESS ADDRESS:	
		STREET 1:		2400 BAYSHORE PARKWAY, SUITE 200
		CITY:			MOUNTAIN VIEW
		STATE:			CA
		ZIP:			94043
		BUSINESS PHONE:		650-386-3100

	MAIL ADDRESS:	
		STREET 1:		2400 BAYSHORE PARKWAY, SUITE 200
		CITY:			MOUNTAIN VIEW
		STATE:			CA
		ZIP:			94043

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			ARMER THOMAS A
		CENTRAL INDEX KEY:			0001413824

	FILING VALUES:
		FORM TYPE:		4
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-33719
		FILM NUMBER:		08548850

	BUSINESS ADDRESS:	
		BUSINESS PHONE:		(650) 386-3100

	MAIL ADDRESS:	
		STREET 1:		2400 BAYSHORE PARKWAY
		STREET 2:		SUITE 200
		CITY:			MOUNTAIN VIEW
		STATE:			CA
		ZIP:			94043
</SEC-HEADER>
<DOCUMENT>
<TYPE>4
<SEQUENCE>1
<FILENAME>rrd191592.xml
<DESCRIPTION>FORM 4
<TEXT>
<XML>
<?xml version="1.0"?>
<ownershipDocument>

    <schemaVersion>X0202</schemaVersion>

    <documentType>4</documentType>

    <periodOfReport>2008-01-22</periodOfReport>

    <notSubjectToSection16>0</notSubjectToSection16>

    <issuer>
        <issuerCik>0001401923</issuerCik>
        <issuerName>MAP Pharmaceuticals, Inc.</issuerName>
        <issuerTradingSymbol>MAPP</issuerTradingSymbol>
    </issuer>

    <reportingOwner>
        <reportingOwnerId>
            <rptOwnerCik>0001413824</rptOwnerCik>
            <rptOwnerName>ARMER THOMAS A</rptOwnerName>
        </reportingOwnerId>
        <reportingOwnerAddress>
            <rptOwnerStreet1>C/O MAP PHARMACEUTICALS, INC.</rptOwnerStreet1>
            <rptOwnerStreet2>2400 BAYSHORE PARKWAY, SUITE 200</rptOwnerStreet2>
            <rptOwnerCity>MOUNTAIN VIEW</rptOwnerCity>
            <rptOwnerState>CA</rptOwnerState>
            <rptOwnerZipCode>94043</rptOwnerZipCode>
            <rptOwnerStateDescription></rptOwnerStateDescription>
        </reportingOwnerAddress>
        <reportingOwnerRelationship>
            <isDirector>1</isDirector>
            <isOfficer>1</isOfficer>
            <isTenPercentOwner>0</isTenPercentOwner>
            <isOther>0</isOther>
            <officerTitle>CSO, Director</officerTitle>
        </reportingOwnerRelationship>
    </reportingOwner>

    <derivativeTable>
        <derivativeTransaction>
            <securityTitle>
                <value>Stock Option (Right to Buy)</value>
            </securityTitle>
            <conversionOrExercisePrice>
                <value>13.12</value>
            </conversionOrExercisePrice>
            <transactionDate>
                <value>2008-01-22</value>
            </transactionDate>
            <transactionCoding>
                <transactionFormType>4</transactionFormType>
                <transactionCode>A</transactionCode>
                <equitySwapInvolved>0</equitySwapInvolved>
            </transactionCoding>
            <transactionAmounts>
                <transactionShares>
                    <value>50000</value>
                </transactionShares>
                <transactionPricePerShare>
                    <value>13.12</value>
                </transactionPricePerShare>
                <transactionAcquiredDisposedCode>
                    <value>A</value>
                </transactionAcquiredDisposedCode>
            </transactionAmounts>
            <exerciseDate>
                <footnoteId id="F1"/>
            </exerciseDate>
            <expirationDate>
                <value>2018-01-21</value>
            </expirationDate>
            <underlyingSecurity>
                <underlyingSecurityTitle>
                    <value>Common Stock</value>
                </underlyingSecurityTitle>
                <underlyingSecurityShares>
                    <value>50000</value>
                </underlyingSecurityShares>
            </underlyingSecurity>
            <postTransactionAmounts>
                <sharesOwnedFollowingTransaction>
                    <value>50000</value>
                </sharesOwnedFollowingTransaction>
            </postTransactionAmounts>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>D</value>
                </directOrIndirectOwnership>
            </ownershipNature>
        </derivativeTransaction>
    </derivativeTable>

    <footnotes>
        <footnote id="F1">The option is exercisable as it vests: 25% of the total number of option shares vests and becomes exercisable on January 22, 2009.  Thereafter, 1/48th of the total number of option shares becomes exercisable cumulatively on the 22nd day of each following month for 36 months so that the entire number of option shares becomes fully vested and exercisable on January 22, 2012.</footnote>
    </footnotes>

    <ownerSignature>
        <signatureName>/s/ Thomas A. Armer, Ph.D.</signatureName>
        <signatureDate>2008-01-23</signatureDate>
    </ownerSignature>
</ownershipDocument>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
-----END PRIVACY-ENHANCED MESSAGE-----